IBM (IBM) Not Immune to Macro Headwinds- UBS

September 28, 2022 2:05 PM EDT Send to a Friend
UBS cut IBM's price target to $112 from $118 on Wednesday, maintaining a Sell rating on the stock, stating the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login